{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:52:56Z","timestamp":1791273176482,"version":"4.1.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.iac.2026.06.002","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T02:22:43Z","timestamp":1785982963000},"page":"581-599","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["New and Emerging Treatments of Food Allergy"],"prefix":"10.1016","volume":"46","author":[{"given":"Jaclyn","family":"Bjelac","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacy","family":"Silvers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Schroer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.iac.2026.06.002_bib1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jaci.2024.10.008","article-title":"Asthma & Immunology. Addressing health disparities in food allergy: a position statement of the AAAAI prior authorization task force","volume":"155","year":"2025","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.iac.2026.06.002_bib2","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.18162","article-title":"Racial, ethnic, and socioeconomic differences in food allergies in the US","volume":"6","author":"Jiang","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10.1016\/j.iac.2026.06.002_bib3","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.anai.2022.04.022","article-title":"Health disparities in pediatric food allergy","volume":"129","author":"Tepler","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"10.1016\/j.iac.2026.06.002_bib4","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.jaci.2023.11.918","article-title":"Feast for thought: a comprehensive review of food allergy 2021-2023","volume":"153","author":"Bartha","year":"2024","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.iac.2026.06.002_bib5","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.jaci.2021.10.018","article-title":"Food allergy across the globe","volume":"148","author":"Sampath","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.iac.2026.06.002_bib6","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.anai.2022.08.012","article-title":"Food insecurity in children and adults with food allergies","volume":"129","author":"Scurlock","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.iac.2026.06.002_bib7","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jaip.2015.11.024","article-title":"The natural history of food allergy","volume":"4","author":"Savage","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"7","key":"10.1016\/j.iac.2026.06.002_bib8","first-page":"743","article-title":"Biomarkers of diagnosis and resolution of food allergy","volume":"31","author":"Foong","year":"2020","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.iac.2026.06.002_bib9","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2025-072593","article-title":"Encouraging trends in peanut allergy prevention: real-world impact of prevention guidelines available","author":"Gupta","year":"2025","journal-title":"Pediatrics"},{"issue":"11","key":"10.1016\/j.iac.2026.06.002_bib10","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1016\/j.jaip.2024.08.006","article-title":"Prevalence and characteristics of accidental ingestions among pediatric food allergy patients","volume":"12","author":"Hsu","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"8","key":"10.1016\/j.iac.2026.06.002_bib11","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s00431-025-06316-0","article-title":"Mental health risks in children with food allergies: a population-based comparison of food allergies with other chronic conditions","volume":"184","author":"Flaks-Manov","year":"2025","journal-title":"Eur J Pediatr"},{"issue":"1","key":"10.1016\/j.iac.2026.06.002_bib12","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jaci.2017.11.005","article-title":"Mechanisms of food allergy","volume":"141","author":"Sampson","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2026.06.002_bib13","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/ACI.0000000000001058","article-title":"New approaches in childhood IgE-mediated food allergy treatment","volume":"25","author":"Gurel","year":"2025","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"8-a Suppl","key":"10.1016\/j.iac.2026.06.002_bib14","first-page":"S1","article-title":"Navigating the landscape of food allergies: insights and perspectives from the AMCP market insights program","volume":"30","author":"Richardson","year":"2024","journal-title":"J Manag Care Spec Pharm"},{"issue":"6","key":"10.1016\/j.iac.2026.06.002_bib15","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/MOP.0000000000001272","article-title":"Updates in food allergen immunotherapy","volume":"35","author":"Szafron","year":"2023","journal-title":"Curr Opin Pediatr"},{"issue":"3","key":"10.1016\/j.iac.2026.06.002_bib16","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jaip.2024.12.005","article-title":"Cost-effectiveness of oral immunotherapy for egg allergy according to age of therapy commencement","volume":"13","author":"Lloyd","year":"2025","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.iac.2026.06.002_bib17","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.3242","article-title":"Estimation of health and economic benefits of commercial peanut immunotherapy products: a cost-effectiveness analysis","volume":"2","author":"Shaker","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"3","key":"10.1016\/j.iac.2026.06.002_bib18","first-page":"313","article-title":"Shared decision-making in food allergy: navigating an exciting era","volume":"12","author":"Anagnostou","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.iac.2026.06.002_bib19","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1016\/j.jaip.2023.03.024","article-title":"Viewing pediatric food oral immunotherapy through an ethical lens \u2014 a narrative systematic review","volume":"11","author":"Bjelac","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.iac.2026.06.002_bib20","article-title":"Goldilocks zone: allergists\u2019 perceptions of family anxiety and investment in food allergy oral immunotherapy","volume":"27","author":"Erol","year":"2025","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"10.1016\/j.iac.2026.06.002_bib21","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/pai.12914","article-title":"Long-term outcome of peanut oral immunotherapy \u2014 real-life experience","volume":"29","author":"Nachshon","year":"2018","journal-title":"Pediatr Allergy Immunol"},{"issue":"2","key":"10.1016\/j.iac.2026.06.002_bib22","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jaip.2018.05.023","article-title":"Real-world experience with peanut oral immunotherapy: lessons learned from 270 patients","volume":"7","author":"Wasserman","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"10322","key":"10.1016\/j.iac.2026.06.002_bib23","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0140-6736(21)02390-4","article-title":"Efficacy and safety of oral immunotherapy in children aged 1-3 years with peanut allergy (the immune tolerance network IMPACT trial): a randomized placebo-controlled study","volume":"399","author":"Jones","year":"2022","journal-title":"Lancet"},{"issue":"10207","key":"10.1016\/j.iac.2026.06.002_bib24","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/S0140-6736(19)31793-3","article-title":"Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomized, double-blind, placebo-controlled, phase 2 study","volume":"394","author":"Chinthrajah","year":"2019","journal-title":"Lancet"},{"issue":"10187","key":"10.1016\/j.iac.2026.06.002_bib25","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/S0140-6736(19)30420-9","article-title":"Oral immunotherapy for peanut allergy (PACE): a systematic review and meta-analysis of efficacy and safety","volume":"393","author":"Chu","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.iac.2026.06.002_bib26","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/MPG.0000000000003631","article-title":"Oral immunotherapy and risk of eosinophilic esophagitis in children: 15 years\u2019 experience","volume":"76","author":"Morales-Cabeza","year":"2023","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"5","key":"10.1016\/j.iac.2026.06.002_bib27","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/j.jaip.2020.12.029","article-title":"Continuous and daily oral immunotherapy for peanut allergy: results from a 2-year open-label follow-on study","volume":"9","author":"Vickery","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.iac.2026.06.002_bib28","article-title":"Peanut oral immunotherapy using 30 mg and 300 mg maintenance doses","author":"Upton","year":"2025","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.iac.2026.06.002_bib29","series-title":"Xolair (omalizumab-igec) prescribing information","year":"2024"},{"issue":"3","key":"10.1016\/j.iac.2026.06.002_bib30","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/all.16451","article-title":"Allergen-specific IgE is a stronger predictor of remission following peanut oral immunotherapy than age in children aged 1-10 years","volume":"80","author":"Ashley","year":"2025","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.iac.2026.06.002_bib31","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.anai.2014.08.004","article-title":"Relation between eosinophilic esophagitis and oral immunotherapy for food allergy: a systematic review with meta-analysis","volume":"113","author":"Lucendo","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.iac.2026.06.002_bib32","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.iac.2019.09.008","article-title":"Sublingual and patch immunotherapy for food allergy","volume":"40","author":"Waldron","year":"2020","journal-title":"Immunol Allergy Clin North Am"},{"issue":"1","key":"10.1016\/j.iac.2026.06.002_bib33","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.anai.2025.03.001","article-title":"The use of grocery-sourced real-food solutions in sublingual immunotherapy for food allergies","volume":"135","author":"Williams","year":"2025","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.iac.2026.06.002_bib34","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jaci.2023.08.032","article-title":"Desensitization and remission after peanut sublingual immunotherapy in 1- to 4-year-old peanut-allergic children: a randomized, placebo-controlled trial","volume":"153","author":"Kim","year":"2024","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2026.06.002_bib35","first-page":"227","article-title":"Peanut component-specific IgE and IgG4 are modulated by sublingual immunotherapy and are associated with remission in 1-4-year-old children","volume":"80","author":"Singh","year":"2025","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.iac.2026.06.002_bib36","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jaci.2011.10.023","article-title":"The safety and efficacy of sublingual and oral immunotherapy for milk allergy","volume":"129","author":"Keet","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"19","key":"10.1016\/j.iac.2026.06.002_bib37","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1056\/NEJMoa2212895","article-title":"Phase 3 trial of epicutaneous immunotherapy in toddlers with peanut allergy","volume":"388","author":"Greenhawt","year":"2023","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.iac.2026.06.002_bib38","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1001\/jama.2019.1113","article-title":"Effect of epicutaneous immunotherapy vs placebo on reaction to peanut protein ingestion among children with peanut allergy: the PEPITES randomized clinical trial","volume":"321","author":"Fleischer","year":"2019","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.iac.2026.06.002_bib39","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2500\/aap.2021.42.210028","article-title":"Intralymphatic immunotherapy for allergic rhinitis: a systematic review and meta-analysis","volume":"42","author":"Werner","year":"2021","journal-title":"Allergy Asthma Proc"},{"issue":"2","key":"10.1016\/j.iac.2026.06.002_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2018.12.780","article-title":"Intralymphatic immunotherapy for peanut allergy: a pilot study (abstract)","volume":"143","author":"Simon","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"2 suppl","key":"10.1016\/j.iac.2026.06.002_bib41","article-title":"Development of a subcutaneous immunotherapy (SCIT) with a modified peanut extract formulation for the treatment of peanut allergy","volume":"143","author":"Larionov","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2026.06.002_bib42","article-title":"Safety and immunopharmacology of ASP0892 in adults or adolescents with peanut allergy: two randomized trials","author":"Ferslew","year":"2023","journal-title":"Allergy"},{"issue":"10","key":"10.1016\/j.iac.2026.06.002_bib43","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1056\/NEJMoa2312382","article-title":"Omalizumab for the treatment of multiple food allergies","volume":"390","author":"Wood","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.iac.2026.06.002_bib44","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.iac.2024.07.004","article-title":"Biologics in food allergies: emerging therapies","volume":"44","author":"Beaudoin","year":"2024","journal-title":"Immunol Allergy Clin North Am"},{"issue":"1","key":"10.1016\/j.iac.2026.06.002_bib45","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/imr.13380","article-title":"Therapeutic monoclonal antibodies in allergy: targeting IgE, cytokine, and alarmin pathways","volume":"328","author":"Eggel","year":"2024","journal-title":"Immunol Rev"},{"issue":"6","key":"10.1016\/j.iac.2026.06.002_bib46","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.jaci.2013.09.046","article-title":"A pilot study of omalizumab to facilitate rapid oral desensitization in high-risk peanut-allergic patients","volume":"132","author":"Schneider","year":"2013","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2026.06.002_bib47","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jaci.2025.05.014","article-title":"Introduction of allergenic foods after treatment with omalizumab","volume":"156","author":"Dantzer","year":"2025","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2026.06.002_bib48","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jaip.2018.09.015","article-title":"Long-term outcome of peanut oral immunotherapy facilitated initially by omalizumab","volume":"7","author":"Yee","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.iac.2026.06.002_bib49","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/ACI.0000000000000736","article-title":"Omalizumab as an adjuvant in food allergen immunotherapy","volume":"21","author":"Dantzer","year":"2021","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.iac.2026.06.002_bib50","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s40261-025-01436-9","article-title":"Efficacy and safety of ligelizumab in chronic spontaneous urticaria: a systematic review and meta-analysis of randomized controlled trials","volume":"45","author":"Vieira","year":"2025","journal-title":"Clin Drug Invest"},{"issue":"15","key":"10.1016\/j.iac.2026.06.002_bib51","doi-asserted-by":"crossref","DOI":"10.1172\/JCI157765","article-title":"IgE-neutralizing UB-221 mAb, distinct from omalizumab and ligelizumab, exhibits CD23-mediated IgE downregulation and relieves urticaria symptoms","volume":"132","author":"Kuo","year":"2022","journal-title":"J Clin Investig"},{"issue":"4","key":"10.1016\/j.iac.2026.06.002_bib52","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/ACI.0000000000000999","article-title":"New evidence in food allergies treatment","volume":"24","author":"Ghelli","year":"2024","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2026.06.002_bib53","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/all.16404","article-title":"Efficacy and safety of dupilumab in children with peanut allergy: a multicenter, open-label, phase II study","volume":"80","author":"Sindher","year":"2025","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.iac.2026.06.002_bib54","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.anai.2025.07.023","article-title":"Food allergy clinical course in children and adolescents treated with dupilumab for atopic dermatitis","volume":"135","author":"Emerson","year":"2025","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"10.1016\/j.iac.2026.06.002_bib55","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/all.16420","article-title":"Dupilumab as an adjunct to oral immunotherapy in pediatric patients with peanut allergy","volume":"80","author":"Chinthrajah","year":"2025","journal-title":"Allergy"},{"issue":"22","key":"10.1016\/j.iac.2026.06.002_bib56","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.131347","article-title":"Phase 2a randomized, placebo-controlled study of anti\u2013IL-33 in peanut allergy","volume":"4","author":"Chinthrajah","year":"2019","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.iac.2026.06.002_bib57","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.anai.2025.04.012","article-title":"Patient outcomes and safety of combination biologic therapy with dupilumab: a systematic review","volume":"135","author":"Keow","year":"2025","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2026.06.002_bib58","article-title":"Clinical Study Using Biologics to Improve Multi-OIT Outcomes (COMBINE) \u2014 ClinicalTrials.gov identifier NCT03679676; trial record (protocol\/arms includes sequential omalizumab \u2192 dupilumab + mOIT)","year":"2018","journal-title":"ClinicalTrials.gov."},{"issue":"2","key":"10.1016\/j.iac.2026.06.002_bib59","article-title":"JAK1 inhibition with abrocitinib decreases allergen-specific basophil and T-cell activation in pediatric peanut allergy","volume":"2","author":"Ramsey","year":"2023","journal-title":"J Allergy Clin Immunol Global"},{"issue":"5","key":"10.1016\/j.iac.2026.06.002_bib60","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1016\/j.jaci.2017.12.987","article-title":"Short-term ibrutinib therapy suppresses skin test responses and eliminates IgE-mediated basophil activation in adults with peanut or tree nut allergy","volume":"141","author":"Dispenza","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"16","key":"10.1016\/j.iac.2026.06.002_bib61","doi-asserted-by":"crossref","DOI":"10.1172\/JCI172335","article-title":"A phase II study of Bruton\u2019s tyrosine kinase inhibition for the prevention of anaphylaxis","volume":"133","author":"Suresh","year":"2023","journal-title":"J Clin Investig"},{"issue":"1","key":"10.1016\/j.iac.2026.06.002_bib62","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jaci.2017.02.046","article-title":"Prevention of food allergy development and suppression of established food allergy by neutralization of thymic stromal lymphopoietin, IL-25, and IL-33","volume":"141","author":"Khodoun","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2026.06.002_bib63","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jaci.2022.02.024","article-title":"A mouse model of the LEAP study reveals a role for CTLA-4 in preventing peanut allergy induced by environmental peanut exposure","volume":"150","author":"Krempski","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"10.1016\/j.iac.2026.06.002_bib64","article-title":"A mixture of four probiotic strains (Probiatop\u00ae) mitigates food allergy to ovalbumin in mice","volume":"17","author":"Miranda","year":"2024","journal-title":"Probiotics Antimicrob Proteins"},{"issue":"3","key":"10.1016\/j.iac.2026.06.002_bib65","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S2352-4642(22)00006-2","article-title":"Probiotic peanut oral immunotherapy versus oral immunotherapy and placebo in children with peanut allergy in Australia (PPOIT-003): a multicentre, randomised, phase 2b trial","volume":"6","author":"Loke","year":"2022","journal-title":"Lancet Child Adolesc Health"},{"issue":"10","key":"10.1016\/j.iac.2026.06.002_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2024.100969","article-title":"Fecal microbiota transplantation alleviates food allergy in neonatal mice via the PD-1\/PD-L1 pathway and change of the microbiota composition","volume":"17","author":"Huang","year":"2024","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.iac.2026.06.002_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2021.101370","article-title":"Use of a liver-targeting nanoparticle platform to intervene in peanut-induced anaphylaxis through delivery of an Ara h2 T-cell epitope","volume":"42","author":"Liu","year":"2022","journal-title":"Nano Today"},{"issue":"10","key":"10.1016\/j.iac.2026.06.002_bib68","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1111\/all.16262","article-title":"Two-year post-treatment outcomes following peanut oral immunotherapy in the probiotic and peanut oral Immunotherapy-003 long-term (PPOIT-003LT) study","volume":"79","author":"Loke","year":"2024","journal-title":"Allergy"},{"issue":"9","key":"10.1016\/j.iac.2026.06.002_bib69","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.32710","article-title":"Racial and ethnic representation in food allergen immunotherapy trial participants: a systematic review","volume":"7","author":"Suffian","year":"2024","journal-title":"JAMA Netw Open"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856126000573?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856126000573?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:26:10Z","timestamp":1791271570000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889856126000573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":69,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0889856126000573"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2026.06.002","relation":{},"ISSN":["0889-8561"],"issn-type":[{"value":"0889-8561","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New and Emerging Treatments of Food Allergy","name":"articletitle","label":"Article Title"},{"value":"Immunology and Allergy Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iac.2026.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}